In addition, for EIF4A2, SRRM1 and HNRNPDL, whose poison exon/intron-included isoforms are basally present in AML cells, overexpression of RBM17 inhibited the inclusion of their poison exons/introns (Supplementary Fig. 4c). Here, RBM17 is linked to acute myeloid leukemia.